{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:06:46Z","timestamp":1648595206220},"reference-count":137,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this review paper, we discuss the characteristics that define severe bronchiectasis and which may lead to deterioration of noncystic fibrosis bronchiectasis. These characteristics were used to establish the current severity scores: bronchiectasis severity index (BSI), FACED, and E-FACED (exacerbation frequency, forced expiratory volume in 1 second, age, colonization, extension and dyspnea score). They can be used to predict mortality, exacerbation rate, hospital admission, and quality of life. Furthermore, there are different treatable traits that contribute to severe bronchiectasis and clinical deterioration. When present, they can be a target of the treatment to stabilize bronchiectasis.<\/jats:p><jats:p>One of the first steps in treatment management of bronchiectasis is evaluation of compliance to already prescribed therapy. Several factors can contribute to treatment adherence, but to date no real interventions have been published to ameliorate this phenomenon. In the second step, treatment in deteriorating patients with bronchiectasis should be guided by the predominant symptoms, for example, cough, sputum, difficulty expectoration, exacerbation rate, or physical impairment. In the third step, we evaluate treatable traits that could influence disease severity in the deteriorating patient. Finally, in patients who are difficult to treat despite maximum medical treatment, eligibility for surgery (when disease is localized), should be considered. In case of end-stage disease, the evaluation for lung transplantation should be performed. Noninvasive ventilation can serve as a bridge to lung transplantation in patients with respiratory failure.<\/jats:p>","DOI":"10.1055\/s-0041-1730946","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T22:34:05Z","timestamp":1626302045000},"page":"623-638","source":"Crossref","is-referenced-by-count":0,"title":["The Deteriorating Patient: Therapies Including Lung Transplantation"],"prefix":"10.1055","volume":"42","author":[{"given":"Stephanie","family":"Detailleur","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, University Hospital Gasthuisberg, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, University Hospital Gasthuisberg, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Goeminne","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, AZ Nikolaas, Sint-Niklaas, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"D Weycker","year":"2017","journal-title":"Chron Respir Dis"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"J K Quint","year":"2016","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rmed.2019.04.007","article-title":"Incidence of patients with non-cystic fibrosis bronchiectasis in Germany: a healthcare insurance claims data analysis","volume":"151","author":"R Diel","year":"2019","journal-title":"Respir Med"},{"issue":"07","key":"ref4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.rmed.2010.02.022","article-title":"Trends in bronchiectasis mortality in England and Wales","volume":"104","author":"H J Roberts","year":"2010","journal-title":"Respir Med"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"e71109","DOI":"10.1371\/journal.pone.0071109","article-title":"Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends","volume":"8","author":"F C Ringshausen","year":"2013","journal-title":"PLoS One"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12890-019-0818-6","article-title":"The economic burden of bronchiectasis - known and unknown: a systematic review","volume":"19","author":"P C Goeminne","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"04","key":"ref7","first-page":"375","article-title":"Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult","volume":"20","author":"J Bahous","year":"1984","journal-title":"Bull Eur Physiopathol Respir"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"J D Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/thorax.55.3.198","article-title":"Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests","volume":"55","author":"H R Roberts","year":"2000","journal-title":"Thorax"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"M A Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"D J Serisier","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"J D Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rmed.2016.08.008","article-title":"Characterization of bronchiectasis in the elderly","volume":"119","author":"G Bellelli","year":"2016","journal-title":"Respir Med"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"M A Mart\u00ednez-Garc\u00eda","year":"2014","journal-title":"Eur Respir J"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"M R Loebinger","year":"2009","journal-title":"Eur Respir J"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterisation of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"J D Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12890-015-0046-7","article-title":"Sedentary behaviour and physical activity in bronchiectasis: a cross-sectional study","volume":"15","author":"J M Bradley","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ptj\/pzx123","article-title":"Determinants of peripheral muscle strength and activity in daily life in people with bronchiectasis","volume":"98","author":"A A de Camargo","year":"2018","journal-title":"Phys Ther"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-6958-7-3","article-title":"Extrapulmonary features of bronchiectasis: muscle function, exercise capacity, fatigue, and health status","volume":"7","author":"O Ozalp","year":"2012","journal-title":"Multidiscip Respir Med"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/1414-431x20154135","article-title":"Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis","volume":"48","author":"Q Qi","year":"2015","journal-title":"Braz J Med Biol Res"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"J Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"1901647","DOI":"10.1183\/13993003.01647-2019","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)","volume":"54","author":"S V Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"W S Lim","year":"2003","journal-title":"Thorax"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"M A Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"M J McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"e0175171","DOI":"10.1371\/journal.pone.0175171","article-title":"Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations","volume":"12","author":"E Rosales-Mayor","year":"2017","journal-title":"PLoS One"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/13993003.01312-2015","article-title":"Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study","volume":"47","author":"H C Ellis","year":"2016","journal-title":"Eur Respir J"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2016-208481","article-title":"Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts","volume":"71","author":"M J McDonnell","year":"2016","journal-title":"Thorax"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874306401509010046","article-title":"Assessment of the non-cystic fibrosis bronchiectasis severity: the FACED score vs the bronchiectasis severity index","volume":"9","author":"J Minov","year":"2015","journal-title":"Open Respir Med J"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1378\/chest.12-1005","article-title":"Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis","volume":"143","author":"P C Goeminne","year":"2013","journal-title":"Chest"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1378\/chest.12-2414","article-title":"Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis","volume":"144","author":"S CL Farhat","year":"2013","journal-title":"Chest"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09603123.2012.708917","article-title":"Effect of residential proximity to major roadways on cystic fibrosis exacerbations","volume":"23","author":"M S Jassal","year":"2013","journal-title":"Int J Environ Health Res"},{"issue":"07","key":"ref33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.200306-779OC","article-title":"Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis","volume":"169","author":"C H Goss","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-014-0108-z","article-title":"Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis","volume":"15","author":"P C Goeminne","year":"2014","journal-title":"Respir Res"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000488646","article-title":"Effect of air pollution on exacerbations of bronchiectasis in Badalona, Spain, 2008-2016","volume":"96","author":"I Garcia-Oliv\u00e9","year":"2018","journal-title":"Respiration"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2147\/COPD.S231317","article-title":"Acute effects of air pollution on hospital admissions for asthma, COPD, and bronchiectasis in Ahvaz, Iran","volume":"15","author":"H Raji","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.02557-2017","article-title":"The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis","volume":"52","author":"P C Goeminne","year":"2018","journal-title":"Eur Respir J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"113654","DOI":"10.1016\/j.ijheh.2020.113654","article-title":"Association of hospital admission for bronchiectasis with air pollution: a province-wide time-series study in southern China","volume":"231","author":"Z Wang","year":"2021","journal-title":"Int J Hyg Environ Health"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/JAS-120004905","article-title":"Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis","volume":"39","author":"R Kumar","year":"2002","journal-title":"J Asthma"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1034\/j.1399-3003.2000.16f13.x","article-title":"Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis","volume":"16","author":"P A Wark","year":"2000","journal-title":"Eur Respir J"},{"issue":"04","key":"ref41","first-page":"333","article-title":"Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis","volume":"70","author":"P A Greenberger","year":"1993","journal-title":"Ann Allergy"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"M C Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"D A Stevens","year":"2000","journal-title":"N Engl J Med"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"E Polverino","year":"2018","journal-title":"Eur Respir J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"109219","DOI":"10.1155\/2013\/109219","article-title":"Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels","volume":"2013","author":"M Luj\u00e1n","year":"2013","journal-title":"BioMed Res Int"},{"issue":"08","key":"ref46","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10875-016-0335-9","article-title":"Asthma and hypogammaglobulinemia: an asthma phenotype with low type 2 inflammation","volume":"36","author":"C Dupin","year":"2016","journal-title":"J Clin Immunol"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis","volume":"108","author":"P C Goeminne","year":"2014","journal-title":"Respir Med"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"e0150532","DOI":"10.1371\/journal.pone.0150532","article-title":"Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Q Du","year":"2016","journal-title":"PLoS One"},{"issue":"S 01","key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"A T Hill","year":"2019","journal-title":"Thorax"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1038\/s41598-018-27680-y","article-title":"Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis","volume":"8","author":"E Crisafulli","year":"2018","journal-title":"Sci Rep"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.rmed.2013.05.004","article-title":"A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease","volume":"107","author":"E Donath","year":"2013","journal-title":"Respir Med"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"J Altenburg","year":"2013","journal-title":"JAMA"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"C Wong","year":"2012","journal-title":"Lancet"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-13-21","article-title":"Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients","volume":"13","author":"P C Goeminne","year":"2012","journal-title":"Respir Res"},{"issue":"07","key":"ref55","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.rmed.2013.04.006","article-title":"Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis","volume":"107","author":"P Mandal","year":"2013","journal-title":"Respir Med"},{"issue":"05","key":"ref56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/resp.12522","article-title":"Hiatal hernias are correlated with increased severity of non-cystic fibrosis bronchiectasis","volume":"20","author":"M J McDonnell","year":"2015","journal-title":"Respirology"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4166\/kjg.2016.68.1.10","article-title":"Effect of proton pomp inhibitors in bronchiectatic patients with gastroesophageal reflux disease","volume":"68","author":"B Ahn","year":"2016","journal-title":"Korean J Gastroenterol"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gutjnl-2011-300926","article-title":"Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period","volume":"61","author":"W O Rohof","year":"2012","journal-title":"Gut"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.clnu.2015.10.001","article-title":"Oral supplement enriched in HMB combined with pulmonary rehabilitation improves body composition and health related quality of life in patients with bronchiectasis (Prospective, Randomised Study)","volume":"35","author":"G Olveira","year":"2016","journal-title":"Clin Nutr"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"779","DOI":"10.14423\/SMJ.0000000000000565","article-title":"Prevalence of osteopenia and osteoporosis in patients with noncystic fibrosis bronchiectasis","volume":"109","author":"N Diehl","year":"2016","journal-title":"South Med J"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"D Ara\u00fajo","year":"2018","journal-title":"Eur Respir J"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"M J McDonnell","year":"2015","journal-title":"Respir Med"},{"issue":"06","key":"ref63","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/resp.12768","article-title":"Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up","volume":"21","author":"J Park","year":"2016","journal-title":"Respirology"},{"issue":"11","key":"ref64","first-page":"1602","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"S Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rmed.2011.11.018","article-title":"Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis","volume":"106","author":"L White","year":"2012","journal-title":"Respir Med"},{"issue":"04","key":"ref66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000438490","article-title":"Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"90","author":"R Orriols","year":"2015","journal-title":"Respiration"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01451-2020","article-title":"Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study","volume":"57","author":"M R Loebinger","year":"2021","journal-title":"Eur Respir J"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"M P Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"E Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0668.2006.00423.x","article-title":"Indoor air quality risk factors for severe lower respiratory tract infections in Inuit infants in Baffin Region, Nunavut: a pilot study","volume":"16","author":"T Kovesi","year":"2006","journal-title":"Indoor Air"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1513\/AnnalsATS.201406-257OC","article-title":"Bronchiectasis in children from Qikiqtani (Baffin) region, Nunavut, Canada","volume":"12","author":"L Das","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<182::AID-PPUL5>3.0.CO;2-T","article-title":"Bronchiectasis in Alaska Native children: causes and clinical courses","volume":"29","author":"R Singleton","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.11-1024","article-title":"Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture","volume":"142","author":"P J McShane","year":"2012","journal-title":"Chest"},{"issue":"06","key":"ref74","first-page":"1","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"A T Hill","year":"2017","journal-title":"Eur Respir J"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2466-14-107","article-title":"Treatment adherence and health outcomes in patients with bronchiectasis","volume":"14","author":"A R McCullough","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/hex.12217","article-title":"\u2018All illness is personal to that individual\u2019: a qualitative study of patients' perspectives on treatment adherence in bronchiectasis","volume":"18","author":"A R McCullough","year":"2015","journal-title":"Health Expect"},{"issue":"11","key":"ref77","first-page":"CD011023","article-title":"Interventions for enhancing adherence to treatment in adults with bronchiectasis","author":"A McCullough","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"ref78","first-page":"CD008351","article-title":"Airway clearance techniques for bronchiectasis","author":"A L Lee","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref79","first-page":"CD011699","article-title":"Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis","volume":"9","author":"A L Lee","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.00055509","article-title":"A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis","volume":"34","author":"M P Murray","year":"2009","journal-title":"Eur Respir J"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-13-21","article-title":"Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis","volume":"13","author":"A Nicolini","year":"2013","journal-title":"BMC Pulm Med"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1378\/chest.1698587","article-title":"Oscillating positive expiratory pressure therapy in chronic obstructive pulmonary diseases and bronchiectasis","author":"S Svenningsen","year":"2013","journal-title":"Chest"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thx.43.1.57","article-title":"Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy","volume":"43","author":"P P Sutton","year":"1988","journal-title":"Thorax"},{"issue":"02","key":"ref84","first-page":"108","article-title":"Effects of ELTGOL and Flutter VRP1\u00ae on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis","volume":"16","author":"F S Guimar\u00e3es","year":"2012","journal-title":"Rev Bras Fisioter"},{"key":"ref85","first-page":"105","volume-title":"Physiotherapy with the VRP-1 device","author":"M Kurz","year":"2017"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pri.507","article-title":"Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis","volume":"17","author":"P HS Figueiredo","year":"2012","journal-title":"Physiother Res Int"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1479972306074481","article-title":"A randomized evaluation of the acute efficacy, acceptability and tolerability of flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis","volume":"4","author":"T Eaton","year":"2007","journal-title":"Chron Respir Dis"},{"issue":"03","key":"ref88","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000085363","article-title":"Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella","volume":"72","author":"J E Patterson","year":"2005","journal-title":"Respiration"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011699.pub2","article-title":"Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial","author":"S Semwal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"05","key":"ref90","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thorax.57.5.446","article-title":"Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis","volume":"57","author":"C S Thompson","year":"2002","journal-title":"Thorax"},{"key":"ref91","first-page":"23","article-title":"A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis","author":"L C De Oliveira Antunes","year":"2001","journal-title":"Rev Salusvita"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1013-7025(09)70037-5","article-title":"Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study","volume":"21","author":"S M Tsang","year":"2003","journal-title":"Hong Kong Physiother J"},{"issue":"05","key":"ref93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of Hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"B Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"12","key":"ref94","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"F Kellett","year":"2011","journal-title":"Respir Med"},{"issue":"05","key":"ref95","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"C HH Nicolson","year":"2012","journal-title":"Respir Med"},{"issue":"10","key":"ref96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"H J Fuchs","year":"1994","journal-title":"N Engl J Med"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/ajrccm.153.2.8564129","article-title":"Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis","volume":"153","author":"B L Laube","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref98","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"A E O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/jamp.2015.1282","article-title":"Ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis or chronic obstructive pulmonary disease, and in healthy volunteers","volume":"30","author":"H Stass","year":"2017","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"A De Soyza","year":"2018","journal-title":"Eur Respir J"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"T Aksamit","year":"2018","journal-title":"Eur Respir J"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00110-2020","article-title":"Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies","volume":"56","author":"J D Chalmers","year":"2020","journal-title":"Eur Respir J"},{"issue":"10","key":"ref103","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"I F Laska","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"09","key":"ref104","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"A F Barker","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00608-2020","article-title":"Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies","volume":"56","author":"M L Crichton","year":"2020","journal-title":"Eur Respir J"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"1479973119872513","DOI":"10.1177\/1479973119872513","article-title":"Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis","volume":"16","author":"M Blanco-Aparicio","year":"2019","journal-title":"Chron Respir Dis"},{"issue":"08","key":"ref107","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"C S Haworth","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref108","first-page":"CD006218","article-title":"Influenza vaccine for children and adults with bronchiectasis","author":"C C Chang","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref109","first-page":"CD006316","article-title":"Pneumococcal vaccines for children and adults with bronchiectasis","author":"C C Chang","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"33","key":"ref110","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1016\/j.vaccine.2008.05.037","article-title":"Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease","volume":"26","author":"A Furumoto","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"ref111","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/thx.2004.028928","article-title":"Exercise training and inspiratory muscle training in patients with bronchiectasis","volume":"60","author":"C Newall","year":"2005","journal-title":"Thorax"},{"issue":"01","key":"ref112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-15-44","article-title":"The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial","volume":"15","author":"A L Lee","year":"2014","journal-title":"Respir Res"},{"issue":"12","key":"ref113","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.rmed.2012.08.004","article-title":"A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis","volume":"106","author":"P Mandal","year":"2012","journal-title":"Respir Med"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1479972310391282","article-title":"Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study","volume":"8","author":"H K Ong","year":"2011","journal-title":"Chron Respir Dis"},{"issue":"05","key":"ref115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/HCR.0b013e3182631314","article-title":"Pulmonary rehabilitation in patients with bronchiectasis: pulmonary function, arterial blood gases, and the 6-minute walk test","volume":"32","author":"M van Zeller","year":"2012","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"04","key":"ref116","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5152\/dir.2017.16454","article-title":"Bronchial artery embolization in hemoptysis: a systematic review","volume":"23","author":"A Panda","year":"2017","journal-title":"Diagn Interv Radiol"},{"issue":"01","key":"ref117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0218492314544310","article-title":"Bronchial artery embolization for massive hemoptysis: long-term follow-up","volume":"23","author":"O Fruchter","year":"2015","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"07","key":"ref118","first-page":"781","article-title":"Haemoptysis due to chronic tuberculosis vs. bronchiectasis: comparison of long-term outcome of arterial embolisation","volume":"11","author":"J-H Lee","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"04","key":"ref119","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-5223(19)37243-5","article-title":"Current results of treatment of bronchiectasis","volume":"83","author":"L S Annest","year":"1982","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"04","key":"ref120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jtcvs.2016.12.004","article-title":"Surgery for predominant lesion in nonlocalized bronchiectasis","volume":"153","author":"J Dai","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"17382","DOI":"10.1038\/srep17382","article-title":"Efficiency and safety of surgical intervention to patients with non-cystic fibrosis bronchiectasis: a meta-analysis","volume":"5","author":"L C Fan","year":"2015","journal-title":"Sci Rep"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1010-7940(01)00689-3","article-title":"Thoracoscopic lobectomy for benign disease--a single centre study on 64 cases","volume":"20","author":"A Weber","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"issue":"01","key":"ref123","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.athoracsur.2010.08.035","article-title":"Video-assisted thoracic surgery for bronchiectasis","volume":"91","author":"P Zhang","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"05","key":"ref124","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1378\/chest.125.5.1815","article-title":"Survival of patients with bronchiectasis after the first ICU stay for respiratory failure","volume":"125","author":"M Dupont","year":"2004","journal-title":"Chest"},{"issue":"04","key":"ref125","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00134-009-1743-6","article-title":"Noninvasive and invasive ventilation in acute respiratory failure associated with bronchiectasis","volume":"36","author":"J Phua","year":"2010","journal-title":"Intensive Care Med"},{"issue":"05","key":"ref126","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijccm.IJCCM_474_17","article-title":"Noninvasive ventilation for acute respiratory failure due to noncystic fibrosis bronchiectasis","volume":"22","author":"V Hadda","year":"2018","journal-title":"Indian J Crit Care Med"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.112.5.1259","article-title":"Long-term efficiency of home nasal mask ventilation in patients with diffuse bronchiectasis and severe chronic respiratory failure: a case-control study","volume":"112","author":"D Benhamou","year":"1997","journal-title":"Chest"},{"issue":"06","key":"ref128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/thx.50.6.604","article-title":"Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders","volume":"50","author":"A K Simonds","year":"1995","journal-title":"Thorax"},{"issue":"01","key":"ref129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"D Weill","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"03","key":"ref130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"K J Ramos","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"10","key":"ref131","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.healun.2004.12.114","article-title":"Lung transplantation for non-cystic fibrosis bronchiectasis: analysis of a 13-year experience","volume":"24","author":"P A Beirne","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"01","key":"ref132","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12890-018-0634-4","article-title":"Outcomes of lung transplantation in adults with bronchiectasis","volume":"18","author":"J Birch","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"06","key":"ref133","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.transproceed.2019.04.036","article-title":"Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience","volume":"51","author":"V Rusanov","year":"2019","journal-title":"Transplant Proc"},{"issue":"10","key":"ref134","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match","volume":"38","author":"D C Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"07","key":"ref135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.healun.2004.05.013","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004","volume":"23","author":"E P Trulock","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2016.04.007","article-title":"Lung transplantation for non-cystic fibrosis bronchiectasis","volume":"115","author":"J Rademacher","year":"2016","journal-title":"Respir Med"},{"issue":"10","key":"ref137","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.healun.2004.11.013","article-title":"The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency","volume":"24","author":"J A Nathan","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1730946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T22:51:38Z","timestamp":1626303098000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1730946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":137,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,7,14]]},"published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1730946","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}